Hidden in Plain Sight: Clinical Profile, Diagnosis, and Outcomes of Cardiac Amyloidosis in Cali, Colombia
- 1Evaristo Garcia Del Valle University Hospital: Hospital Universitario Del Valle Evaristo Garcia
Abstract
BackgroundCardiac amyloidosis is an increasingly recognized cause of heart failure in older adults, yet data from Colombia and, in particular, from the countrys southwest region remain scarce. We describe the clinical, diagnostic, imaging, and outcome profile of patients with cardiac amyloidosis at two high-complexity institutions in Cali.
MethodsObservational, descriptive, retrospective, two-center study. Patients were identified through the institutional registries of both centers using ICD-10 diagnostic codes for amyloidosis, and clinical information was collected manually from medical records. Continuous variables are reported as median (interquartile range) and categorical variables as counts and percentages, with the number of patients with available data specified for each variable.
ResultsThirty-two patients were analyzed (median age 77 years; 68.8% men). Heart failure was nearly universal (90.6%) and atrial fibrillation was frequent (46.9%); carpal tunnel syndrome was present in 31.2%. Bone scintigraphy showed positive myocardial uptake (Perugini 2-3) in 88.5%, and the Val142Ile variant was found in all genotyped patients, consistent with a predominance of transthyretin amyloidosis. Left ventricular ejection fraction was preserved in most patients despite marked concentric hypertrophy. Tafamidis was used in 37.5%. Overall mortality was 35.5%, and NT-proBNP was markedly higher among patients who died (median 6640 vs 1186 pg/mL; p=0.003).
ConclusionsIn this southwest Colombian cohort, cardiac amyloidosis presented as the classic transthyretin phenotype of the older male with hypertrophic, non-dilated heart failure, a high yield of non-invasive diagnosis, and a striking predominance of the Val142Ile variant. Mortality was high and closely linked to NT-proBNP.
Related
- One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices
- Molecular Reclassification of Diffuse Gliomas: A Feasibility Study of Clinical Features and Survival Outcomes in Colombia
- Cardiovascular risk profile and treatment patterns in patients with type 2 diabetes in specialized cardiology outpatient care in Colombia : A retrospective cross-sectional study
- Clinical profile, risk factors and in-hospital outcomes of ST-segment elevation myocardial infarction in young versus older adults: a 5-year retrospective cohort study at a tertiary care centre in Riyadh, Saudi Arabia.
- Dual cardiac amyloidosis with AL cardiomyopathy and ATTR cardiomyopathy in systemic AL amyloidosis: Recommendation for a myocardial histology-based diagnosis
BibTeX
@misc{barbosabalaguera2026hidden,
title = {{Hidden in Plain Sight: Clinical Profile, Diagnosis, and Outcomes of Cardiac Amyloidosis in Cali, Colombia}},
author = {S. Barbosa-Balaguera and O. Castano and E. J. Echeverry and C. D. M. Llano and A. J. Muriel Ruiz and J. B. Diaz and A. M. T. Cordoba and S. Ayala-Zapata and L. A. Velasquez-Trujillo and A. H. Escandon},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.15.26365704},
url = {https://www.medrxiv.org/content/10.64898/2026.10.15.26365704v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Hidden in Plain Sight: Clinical Profile, Diagnosis, and Outcomes of Cardiac Amyloidosis in Cali, Colombia
AU - S. Barbosa-Balaguera
AU - O. Castano
AU - E. J. Echeverry
AU - C. D. M. Llano
AU - A. J. Muriel Ruiz
AU - J. B. Diaz
AU - A. M. T. Cordoba
AU - S. Ayala-Zapata
AU - L. A. Velasquez-Trujillo
AU - A. H. Escandon
PY - 2026
DA - 2026/10/15
PB - medRxiv
DO - 10.64898/2026.10.15.26365704
UR - https://www.medrxiv.org/content/10.64898/2026.10.15.26365704v1
AB - BackgroundCardiac amyloidosis is an increasingly recognized cause of heart failure in older adults, yet data from Colombia and, in particular, from the countrys southwest region remain scarce. We describe the clinical, diagnostic, imaging, and outcome profile of patients with cardiac amyloidosis at two high-complexity institutions in Cali. MethodsObservational, descriptive, retrospective, two-center study. Patients were identified through the institutional registries of both centers using ICD-10 diagnostic codes for amyloidosis, and clinical information was collected manually from medical records. Continuous variables are reported as median (interquartile range) and categorical variables as counts and percentages, with the number of patients with available data specified for each variable. ResultsThirty-two patients were analyzed (median age 77 years; 68.8% men). Heart failure was nearly universal (90.6%) and atrial fibrillation was frequent (46.9%); carpal tunnel syndrome was present in 31.2%. Bone scintigraphy showed positive myocardial uptake (Perugini 2-3) in 88.5%, and the Val142Ile variant was found in all genotyped patients, consistent with a predominance of transthyretin amyloidosis. Left ventricular ejection fraction was preserved in most patients despite marked concentric hypertrophy. Tafamidis was used in 37.5%. Overall mortality was 35.5%, and NT-proBNP was markedly higher among patients who died (median 6640 vs 1186 pg/mL; p=0.003). ConclusionsIn this southwest Colombian cohort, cardiac amyloidosis presented as the classic transthyretin phenotype of the older male with hypertrophic, non-dilated heart failure, a high yield of non-invasive diagnosis, and a striking predominance of the Val142Ile variant. Mortality was high and closely linked to NT-proBNP.
ER -